In:
Iranian Journal of Pharmaceutical Research, Briefland, Vol. 21, No. 1 ( 2022-03-30)
Abstract:
: More than a year after the onset of the coronavirus disease pandemic in 2019, the disease remains a major global health issue. During this time, health organizations worldwide have tried to provide integrated treatment guidelines to control coronavirus disease 2019 (COVID-19) at different levels. However, due to the novel nature of the disease and the emergence of new variants, medical teams' updating medical information and drug prescribing guidelines should be given special attention. This version is an updated instruction of the National Research Institute of Tuberculosis and Lung Disease (NRITLD) in collaboration with a group of specialists from Masih Daneshvari Hospital in Tehran, Iran, which is provided to update the information of caring clinicians for the treatment and care of COVID-19 hospitalized patients.
Type of Medium:
Online Resource
ISSN:
1735-0328
,
1726-6890
Language:
Unknown
Publisher:
Briefland
Publication Date:
2022
detail.hit.zdb_id:
2578271-X
Bookmarklink
